血小板在肿瘤转移中的作用

作者：王韵壹、李英、熊慧卿

[1] Repsold L, Joubert AM. Platelet function, role in thrombosis, inflammation, and consequences in chronic myeloproliferative disorders [J]. Cells, 2021,10(11):3034
[2] Thong HK, Sugumaran V, Mohamad Mahbob HB, et al. Metastatic carcinoma of the lung presenting as jugular venous thrombosis: A valuable clinical lesson [J]. J Med Life, 2021,14(3): 419-423
[3] Tranum BL, Haut A. Thrombocytosis: Platelet kinetics in neoplasia [J]. J Lab Clin Med, 1974, 84(5):615-619
[4] Braun A, Anders HJ, Gudermann T, et al. Platelet-cancer interplay: Molecular mechanisms and new therapeutic avenues [J]. Front Oncol, 2021,11:665534
[5] Stone RL, Nick AM, McNeish IA, et al. Paraneoplastic thrombocytosis in ovarian cancer [J]. N Engl J Med, 2012,366(7):610-618
[6] Mege D, Aubert M, Lacroix R, et al. Involvement of platelets in cancers [J]. Semin Thromb Hemost, 2019,45(6):569-575
[7] Yang WJ, Zhang GL,Cao KX,et al. A hypercoagulable hematological metastasis breast cancer model [J]. Biomed Res Int, 2021,2021:5473959
[8] Nazari M, Javandoost E, Talebi M, et al. Platelet microparticle controversial role in cancer [J]. Adv Pharm Bull, 2021,11(1):39-55
[9] Camerer E, Qazi AA, Duong DN, et al. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis [J]. Blood, 2004,104(2):397-401
[10] Fang L, Xu Q, Qian J, et al. Aberrant factors of fibrinolysis and coagulation in pancreatic cancer [J]. Onco Targets Ther, 2021,14:53-65
[11] Guerrero JA, Bennett C, van der Weyden L, et al. Gray platelet syndrome: Proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice [J]. Blood, 2014,124(24):3624-3635
[12] Fidler IJ. Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2’-deoxyuridine [J]. J Natl Cancer Inst, 1970,45(4):773-782
[13] Geranpayehvaghei M, Dabirmanesh B, Khaledi M, et al. Cancer-associated-platelet-inspired nanomedicines for cancer therapy [J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2021, 13(5):e1702
[14] Liu Y, Zhang Y, Ding Y, et al. Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules [J]. Crit Rev Oncol Hematol, 2021,167:103502
[15] Schmied L, Höglund P, Meinke S. Platelet-mediated protection of cancer cells from immune surveillance - possible implications for cancer immunotherapy [J]. Front Immunol, 2021,12: 640578
[16] Placke T, Örgel M, Schaller M, et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells [J]. Cancer Res, 2012,72(2):440-448
[17] Palumbo JS, Talmage KE, Massari JV, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells [J]. Blood, 2005, 105(1):178-185
[18] Nieswandt B, Hafner M, Echtenacher B, et al. Lysis of tumor cells by natural killer cells in mice is impeded by platelets [J]. Cancer Res, 1999,59(6):1295-1300
[19] Garner H, de Visser KE. Immune crosstalk in cancer progression and metastatic spread: A complex conversation [J]. Nat Rev Immunol, 2020,20(8):483-497
[20] Placke T, Salih HR, Kopp HG. GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity [J]. J Immunol, 2012,189(1):154-160
[21] Rachidi S, Metelli A, Riesenberg B, et al. Platelets subvert T cell immunity against cancer via GARP-TGFβ axis [J]. Sci Immunol, 2017,2(11): eaai7911
[22] Sang Y, Roest M, de Laat B, et al. Interplay between platelets and coagulation [J]. Blood Rev, 2021,46:100733
[23] Xu XR, Carrim N, Neves MA, et al. Platelets and platelet adhesion molecules: Novel mechanisms of thrombosis and anti-thrombotic therapies [J]. Thromb J, 2016,14(Suppl 1):29
[24] Fabricius H, Starzonek S, Lange T. The role of platelet cell surface P-selectin for the direct platelet-tumor cell contact during metastasis formation in human tumors [J]. Front Oncol, 2021,11:642761
[25] Qi CL, Wei B, Ye J, et al. P-selectin-mediated platelet adhesion promotes the metastasis of murine melanoma cells [J]. PLoS One, 2014,9(3):e91320
[26] Sharma D, Brummel-Ziedins KE, Bouchard BA, et al. Platelets in tumor progression: A host factor that offers multiple potential targets in the treatment of cancer [J]. J Cell Physiol, 2014,229 (8):1005-1015
[27] Schlesinger M. Role of platelets and platelet receptors in cancer metastasis [J]. J Hematol Oncol, 2018,11(1):125
[28] Becker KA, Beckmann N, Adams C, et al. Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets [J]. Clin Exp Metastasis, 2017,34(1):25-35
[29] McCarty OJ, Mousa SA, Bray PF, et al. Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions [J]. Blood, 2000,96(5): 1789-1797
[30] Felding-Habermann B, Habermann R, Saldívar E, et al. Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow [J]. J Biol Chem, 1996,271(10):5892-5900
[31] Zhang C, Liu Y, Gao Y, et al. Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo [J]. Int J Cancer, 2009,125(9):2058-2065
[32] Bakewell SJ, Nestor P, Prasad S, et al. Platelet and osteoclast beta3 integrins are critical for bone metastasis [J]. Proc Natl Acad Sci U S A, 2003,100(24):14205-14210
[33] Mammadova-Bach E, Zigrino P, Brucker C, et al. Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9 [J]. JCI Insight, 2016,1(14): e88245
[34] Jain S, Zuka M, Liu J, et al. Platelet glycoprotein Ib alpha supports experimental lung metastasis [J]. Proc Natl Acad Sci U S A, 2007,104(21):9024-9028
[35] Qi Y, Chen W, Liang X, et al. Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction [J]. J Hematol Oncol, 2018,11(1):117
[36] Erpenbeck L, Nieswandt B, Schon M, et al. Inhibition of platelet GPIb alpha and promotion of melanoma metastasis [J]. J Invest Dermatol, 2010,130(2):576-586
[37] Peyruchaud O, Saier L, Leblanc R. Autotaxin implication in cancer metastasis and autoimunne disorders: Functional implication of binding autotaxin to the cell surface [J]. Cancers (Basel), 2019,12(1): 105
[38] Tímár J, Tóvári J, Rásó E, et al. Platelet-mimicry of cancer cells: Epiphenomenon with clinical significance [J]. Oncology, 2005,69(3):185-201
[39] Machado EA, Gerard DA, Mitchell JR, et al. Arrest and extravasation of neoplastic cells. An electron microscopy study of serial sections at sequential stages [J]. Virchows Arch A Pathol Anat Histol, 1982,396(1):73-89
[40] Enns A, Gassmann P, Schlüter K, et al. Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids [J]. J Gastrointest Surg, 2004,8(8):1049-1059,discussion 1060
[41] Im JH, Fu W, Wang H, et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation [J]. Cancer Res, 2004,64(23):8613-8619
[42] Amos SE, Choi YS. The cancer microenvironment: Mechanical challenges of the metastatic cascade [J]. Front Bioeng Biotechnol, 2021,9:625859
[43] Watanabe N, Kidokoro M, Tanaka M, et al. Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells [J]. Cancer Cell Int, 2020,20:263
[44] Brabletz S, Schuhwerk H, Brabletz T, et al. Dynamic EMT: A multi-tool for tumor progression [J]. EMBO J, 2021,40(18):e108647
[45] Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis [J]. Cancer Cell, 2011,20(5): 576-590
[46] Guo Y, Cui W, Pei Y, et al. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway [J]. Gynecol Oncol, 2019,153(3): 639-650
[47] Zuo XX, Yang Y, Zhang Y, et al. Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: Surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway [J]. Cell Commun Signal, 2019,17(1):142
[48] Dovizio M, Maier TJ, Alberti S, et al. Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells [J]. Mol Pharmacol, 2013,84(1):25-40
[49] Zhang Y, Unnithan RVM, Hamidi A, et al. Tank-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells [J]. FASEB J, 2019,33(7):7822-7832
[50] Tang M, Jiang L, Lin Y, et al. Platelet microparticle-mediated transfer of miR-939 to epithelial ovarian cancer cells promotes epithelial to mesenchymal transition [J]. Oncotarget, 2017,8(57): 97464-97475
[51] Schumacher D, Strilic B, Sivaraj KK, et al. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor [J]. Cancer Cell, 2013,24(1):130-137
[52] Mammadova-Bach E, Mangin P, Lanza F, et al. Platelets in cancer. From basic research to therapeutic implications [J]. Hamostaseologie, 2015,35(4):325-336
[53] Ward Y, Lake R, Faraji F, et al. Platelets promote metastasis via binding tumor CD97 leading to bidirectional signaling that coordinates transendothelial migration [J]. Cell Rep, 2018,23(3): 808-822
[54] Maurer S, Kopp HG, Salih HR, et al. Modulation of immune responses by platelet-derived ADAM10 [J]. Front Immunol, 2020,11:44
[55] Gkolfinopoulos S, Jones RL, Constantinidou A. The emerging role of platelets in the formation of the micrometastatic niche: Current evidence and future perspectives [J]. Front Oncol, 2020,10: 374
[56] Wang Y, Sun Y, Li D, et al. Platelet P2Y12 is involved in murine pulmonary metastasis [J]. PLoS One, 2013,8(11):e80780
[57] Labelle M, Begum S, Hynes RO. Platelets guide the formation of early metastatic niches [J]. Proc Natl Acad Sci U S A, 2014,111(30):E3053-3061
[58] Nasrollahzadeh E, Razi S, Keshavarz-Fathi M, et al. Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site [J]. Cancer Immunol Immunother, 2020,69(9):1673-1697
[59] Lucotti S, Cerutti C, Soyer M, et al. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2 [J]. J Clin Invest, 2019,129(5):1845-1862
[60] Kerr BA, Harris KS, Shi L, et al. Platelet TSP-1 controls prostate cancer-induced osteoclast differentiation and bone marrow-derived cell mobilization through TGFβ-1 [J]. Am J Clin Exp Urol, 2021,9(1):18-31
[61] Rothwell PM, Wilson M, Price JF, et al. Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials [J]. Lancet, 2012,379(9826):1591-1601
[62] Xu XR, Yousef GM, Ni H. Cancer and platelet crosstalk: Opportunities and challenges for aspirin and other antiplatelet agents [J]. Blood, 2018,131(16):1777-1789
[63] Pu D, Yin L, Huang L, et al. Cyclooxygenase-2 inhibitor: A potential combination strategy with immunotherapy in cancer [J]. Front Oncol, 2021,11:637504
[64] Sostres C, Gargallo CJ, Lanas A. Aspirin, cyclooxygenase inhibition and colorectal cancer [J]. World J Gastrointest Pharmacol Ther, 2014,5(1):40-49
[65] Leader A, Zelikson-Saporta R, Pereg D, et al. The effect of combined aspirin and clopidogrel treatment on cancer incidence [J]. Am J Med, 2017,130(7):826-832
[66] Nanau RM, Delzor F, Neuman MG. Efficacy and safety of prasugrel in acute coronary syndrome patients [J]. Clin Biochem, 2014,47(7-8):516-528
[67] Gebremeskel S, LeVatte T, Liwski RS, et al. The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer [J]. Int J Cancer, 2015,136(1):234-240
[68] 石屹城, 宋晓伟, 赵仙先, 等. P2Y12受体拮抗剂对裸鼠移植瘤生长的影响 [J]. 上海交通大学学报(医学版) (Shi YC, Song XW, Zhao XX, et al. Effects of P2Y12 receptor antagonist on growth of transplanted tumor of nude mice [J]. J Shanghai Jiaotong Univ: Med Sci), 2015,35 (06):809-812
[69] Simonato D, Borchert RJ, Labeyrie MA, et al. Glycoprotein IIb/IIIa inhibitors for the neurointerventionalist [J]. Interv Neuroradiol,2022,28(1):84-91
[70] Zhao F, Li L, Guan L, et al. Roles for GPIIb/IIIa and αvβ3 integrins in MDA-MB-231 cell invasion and shear flow-induced cancer cell mechanotransduction [J]. Cancer Lett, 2014,344(1): 62-73
[71] Kononczuk J, Surazynski A, Czyzewska U, et al. αIIbβ3-integrin ligands: Abciximab and Eptifibatide as proapoptotic factors in MCF-7 human breast cancer cells [J]. Curr Drug Targets, 2015,16(13):1429-1437
[72] Amirkhosravi A, Mousa SA, Amaya M, et al. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GPIIb/IIIa antagonist XV454 [J]. Thromb Haemost, 2003,90(3):549-554
[73] Okoshi H, Hakomori S, Nisar M, et al. Cell membrane signaling as target in cancer therapy. II: Inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation [J]. Cancer Res, 1991,51(22):6019-6024
[74] Inufusa H, Adachi T, Nakamura M, et al. Inhibition of experimental metastasis of human adenocarcinoma by cilostazol, a platelet phosphodiesterase inhibitor [J]. Oncol Rep, 1995,2(6): 1079-1083
[75] Tzanakakis GN, Agarwal KC, Vezeridis MP. Prevention of human pancreatic cancer cell-induced hepatic metastasis in nude mice by dipyridamole and its analog RA-233 [J]. Cancer, 1993,71(8):2466-2471
[76] Rhodes EL, Misch KJ, Edwards JM, et al. Dipyridamole for treatment of melanoma [J]. Lancet, 1985,1(8430):693
[77] Gresele P, Malvestiti M, Momi S. Anti-platelet treatments in cancer: Basic and clinical research [J]. Thromb Res, 2018,164 Suppl 1:S106-S111
[78] Haemmerle M, Stone RL, Menter DG, et al. The platelet lifeline to cancer: Challenges and opportunities [J]. Cancer Cell, 2018,33(6):965-983
[79] Voors-Pette C, Lebozec K, Dogterom P, et al. Safety and tolerability, pharmacokinetics, and pharmacodynamics of ACT017, an antiplatelet GPVI (glycoprotein VI) Fab [J]. Arterioscler Thromb Vasc Biol, 2019,39(5):956-964
[80] Schüpke S, Hein-Rothweiler R, Mayer K, et al. Revacept, a novel inhibitor of platelet adhesion, in patients undergoing elective PCI-design and rationale of the randomized ISAR-PLASTER trial [J]. Thromb Haemost, 2019,119(9):1539-1545
[81] Borst O, Gawaz M. Glycoprotein VI - novel target in antiplatelet medication [J]. Pharmacol Ther, 2021,217:107630
[82] Constantinescu-Bercu A, Wang YA, Woollard KJ, et al. The GPIbα intracellular tail - role in transducing vWF- and collagen/GPVI-mediated signaling [J]. Haematologica, 2022,107(4): 933-946
[83] Li BX, Dai X, Xu XR, et al. In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα [J]. Sci Rep, 2021,11(1):11663